Life After Esophageal Repair: How Endoscopic Vacuum Therapy Impacts Long-Term Quality of Life
"Discover how a minimally invasive approach to treating upper GI tract defects can lead to a satisfactory quality of life for patients."
Anastomotic leakages and perforations in the upper gastrointestinal tract (uGIT) can be serious complications. Fortunately, endoscopic vacuum therapy (EVT) has emerged as a successful treatment option. But what about life after the procedure? How does EVT impact a patient's long-term quality of life (QoL)?
Previously, there was a lack of data on the long-term quality of life following successful EVT for uGIT defects. Now, a recent prospective survey provides valuable insights by assessing the QoL of patients treated with EVT and comparing their outcomes to those who underwent esophagectomy without experiencing anastomotic insufficiency.
This article delves into the findings of this survey, exploring how EVT affects various aspects of a patient's life and highlighting the factors that contribute to a better overall QoL after undergoing this innovative treatment.
EVT and Quality of Life: What the Research Shows

The study, published in the Journal of Gastrointestinal Surgery, assessed the long-term QoL of 52 patients treated with EVT for uGIT defects. Researchers compared these patients with 63 individuals who had undergone esophagectomy without experiencing anastomotic insufficiency. The Gastrointestinal Quality of Life-Index (GIQLI) score, determined through a 36-item questionnaire, was used to evaluate QoL.
- Overall QoL: The median GIQLI score did not significantly differ between the EVT group and the non-EVT group, indicating a similar overall quality of life.
- Specific Categories: While most categories showed no significant difference, the "social function" category favored patients who did not undergo EVT. However, other categories like 'symptoms', 'emotions', 'physical functions', and 'medical treatment' were comparable between both groups.
- Factors Influencing QoL: A high GIQLI score was associated with a low ASA score (indicating better overall health), a benign pathology, and a shorter hospital stay (less than 21 days).
The Future of EVT and Quality of Life
This research provides valuable insights into the long-term impact of EVT on patient QoL. As EVT becomes increasingly recognized as a safe and effective treatment for uGIT defects, understanding its effects on various aspects of a patient's life is crucial.
While this study offers promising results, further research is needed to explore specific factors that may influence QoL after EVT. Future studies could focus on larger patient cohorts, different types of uGIT defects, and the impact of EVT compared to other treatment modalities.
Ultimately, EVT offers a promising approach to managing uGIT defects without negatively impacting long-term QoL. By addressing the underlying issue and supporting patients throughout the treatment process, healthcare professionals can help individuals regain their health and maintain a satisfactory quality of life.